Skip to content

DocGo DCGO Cash Provided by (Used in) Financing Activity, Including Discontinued Operation

Cash Provided by (Used in) Financing Activity, Including Discontinued Operation at other companies

Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
-$33.87M+68.4%
ARD
Ardent Health PartnersARDT
-$11.79M+14.8%
Medline, Inc.
 logo
Medline, Inc. MDLN
-$13M-44.4%
CVS Health logo
CVS HealthCVS
Amazon logo
AmazonAMZN

Other financials

Income statement

See full
Revenue$75.6M-21.3%
Gross profit-$407.9M-25.6%
Operating income-$18.7M-33.7%
Net income-$14.8M-57.0%
EPS (diluted)-$0.15-66.7%

Balance sheet

See full
Cash & equivalents$46.8M-54.6%
Total debt$28.5M-7.6%
Total equity$132.3M-57.2%
Total assets$209.2M-51.4%

Cash flow

See full
Operating cash flow-$4.7M-151%
CapEx$430.3K-58.2%
Free cash flow-$5.1M-162%

Valuation

See full
Market cap$50.98M-67.2%
Enterprise value$32.67M-59.1%
P/S0.2×-0.2×

Profitability

See full
Operating margin-60.6%
Net margin-62.2%
FCF margin14.6%+8.1pp

Returns & leverage

See full
Return on equity-85%
Debt / equity0.2×+0.1×
Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's cash provided by (used in) financing activity, including discontinued operation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is DocGo's cash provided by (used in) financing activity, including discontinued operation?
DocGo (DCGO) reported cash provided by (used in) financing activity, including discontinued operation of -$2.46M in Q1 2026.
How has DocGo's cash provided by (used in) financing activity, including discontinued operation changed year-over-year?
DocGo's cash provided by (used in) financing activity, including discontinued operation increased by 71.1% year-over-year, from -$8.52M to -$2.46M.
What is the long-term trend for DocGo's cash provided by (used in) financing activity, including discontinued operation?
Over 3 years (2021 to 2025), DocGo's cash provided by (used in) financing activity, including discontinued operation has grown at a -31.2% compound annual growth rate (CAGR), from $156.13M to -$50.82M.
What does cash provided by (used in) financing activity, including discontinued operation mean?
This metric measures the net cash flow between the company and its capital providers, including proceeds from debt or equity issuance and payments for dividends or share repurchases. It highlights how the company finances its operations and returns value to shareholders.